Group 1 - The company, Jieya Co., Ltd. (SZ 301108), announced that it will hold an investor research meeting on July 30, 2025, with participation from the Deputy General Manager and Board Secretary, Hu Nenghua [2] - For the year 2024, Jieya Co., Ltd.'s revenue composition indicates that the manufacturing of other daily chemical products accounts for 98.53% of total revenue, while other businesses contribute 1.47% [2]

人民财讯7月30日电，7月30日，洁雅股份（301108）在接待机构调研中表示，2025年二季度以来，公司 湿巾业务订单充足，存量客户订单稳定，并承接了部分关键客户欧洲和加拿大市场新增业务。同时，公 司正在积极拓展国际品牌客户的其他区域市场业务。 ...

人民财讯7月30日电，7月30日，洁雅股份（301108）在接待机构调研中表示，美国湿巾工厂项目目前处 在建设期，预计明年可以投产。美国工厂虽面临较高人工成本，但产品溢价空间较高，同时工厂将通过 引入自动化生产线和优化管理流程，实现运营效率提升和成本结构优化。 ...

Company Overview - Tongling Jieya Biotechnology Co., Ltd. was established in 1999, specializing in the research, production, and sales of wet wipes, with over 20 years of industry experience [1] - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 3, 2021, and is steadily advancing its fundraising projects [1] - In Q1 2025, the company reported a revenue of 124 million yuan and a net profit of 1,006.27 thousand yuan [1] U.S. Factory Development - The U.S. wet wipes factory is currently under construction and is expected to commence production next year [2] - To manage higher labor costs in the U.S., the factory will implement automated production lines and optimize management processes to enhance operational efficiency and cost structure [2] - Key investment risks for the U.S. factory include uncertainties in facility renovation and approval processes, customer audit outcomes, potential delays in production start, and cultural differences affecting production efficiency [2] Customer Relations and Market Strategy - The company primarily relies on forecast orders from clients, which are mostly well-known global enterprises, ensuring stable cooperation [3] - The company is focused on optimizing its business structure and enhancing core competitiveness through technological innovation [3] - The Shanghai R&D center is dedicated to independent research and development of cosmetic formulations and collaboration with domestic and international clients [3] Business Performance and Future Outlook - Since Q2 2025, the wet wipes business has seen a stable order flow, with existing clients maintaining orders and new business opportunities in Europe and Canada [4] - The company is actively expanding its market presence with international brand clients [4] - Future business drivers include expanding product categories and sales regions based on existing brand clients and leveraging the U.S. factory [4] Financial Management - The company has approximately 600 million yuan of idle fundraising capital allocated for principal-protected financial products, ensuring the safety of investments while supporting ongoing projects [4] - The company adheres to regulatory guidelines to prevent the disclosure of undisclosed significant information during investor communications [4]

Investment Rating - The report assigns a "Buy" rating for the company, indicating a positive outlook for the stock price in the next six months [5]. Core Insights - The company has launched a three-year incentive plan, granting 1.82 million shares, which is 1.62% of the total share capital, to ten key personnel, including executives [1]. - The company is a leading manufacturer in the wet wipes sector, ranking 4th, 9th, and 8th in China from 2021 to 2023 based on sales [2]. - Revenue has shown slight fluctuations from 2020 to 2024, with figures of 667 million, 623 million, and 547 million respectively, primarily due to changing demand post-pandemic [2]. - The company has a robust order book with major clients including Woolworths, Kimberly-Clark, Johnson & Johnson, and Procter & Gamble, and is actively expanding its international client base [2]. - Domestic production capacity is ramping up, with a projected annual capacity of 18.7 billion pieces by the end of 2024, while a new North American facility is set to begin production in Q1 2026 [3]. - Revenue projections for 2025-2027 are estimated at 743 million, 937 million, and 1.151 billion respectively, with corresponding net profits of 69 million, 83 million, and 108 million [4]. Financial Summary - The company reported a revenue of 623 million in 2023, with a projected decline of 12.07% in 2024, followed by a significant recovery of 35.8% in 2025 [4]. - The net profit for 2023 was 115 million, with a drastic forecasted drop to 19 million in 2024, but expected to rebound to 69 million in 2025 [4]. - The earnings per share (EPS) is projected to increase from 0.24 in 2024 to 0.96 in 2027, reflecting a positive growth trajectory [4].

Group 1: Overseas Policy - The report analyzes three potential scenarios regarding Trump's influence on the Federal Reserve's independence, including the nomination of aggressive rate-cutting candidates, cautious candidates, or the legal removal of Powell [2][7][9] - The current high-interest rate environment is straining the U.S. government's finances, with a potential $100 billion annual savings for every 25 basis points cut by the Fed [7][8] Group 2: Battery Industry - The report highlights the advantages of lithium metal anodes, which include high specific capacity and low electrode potential, positioning them as a long-term technological evolution direction for anodes [3][11] - The market potential for lithium metal anodes is estimated to be between 12 billion to 36 billion yuan, with a corresponding demand for lithium metal ranging from 961 tons to 2884 tons [3][11] - The report emphasizes the competitive landscape in the anode industry, driven by lithium companies, anode manufacturers, and foil material suppliers, with a focus on technological advancements [11][12][13] Group 3: Beauty and Personal Care Industry - The report discusses the stock incentive plan of Jieya Co., which aims for significant revenue growth, with targets of at least 25%, 50%, and 100% growth from 2024 to 2027 [15][17] - The company is expanding its product lines and enhancing its production capacity, particularly in the wet wipes segment, with a focus on high-end products to improve profit margins [16][17] - Jieya Co. is also diversifying into medical and beauty sectors, leveraging its existing technology and partnerships to create a stable supply chain and expand its market presence [16][17] Group 4: Market Overview - The report notes the recent performance of major domestic and overseas indices, highlighting fluctuations and the need to focus on sectors like solid-state batteries and AI hardware for potential investment opportunities [4][6][19] - It suggests that the market may experience short-term volatility but could regain upward momentum in the medium to long term due to policy benefits and industry upgrades [21]

Group 1 - The core viewpoint of the news is that YuDe Investment has conducted research on a listed company, JieYa Co., which aims to expand its global business by increasing its overseas sales proportion to over 50% by 2025 [1] - JieYa Co. is currently constructing a wet wipe factory in the United States, expected to commence production next year, utilizing automated production lines and optimized management processes to control costs [1] - The company faces risks related to factory renovation and approval processes, customer audits, production timelines, and cultural differences between China and the U.S. [1] Group 2 - JieYa Co. has a stable order book for its wet wipe business and has secured additional business from key clients in Europe and Canada [1] - The cosmetics business primarily focuses on OEM for international brands while also expanding into domestic clients, although the order scale remains small [1] - The collagen business is in a strategic adjustment phase with no substantial progress made yet, while the development of its own brand has not met initial expectations, leading to a significant reduction in investment [1] Group 3 - The future business drivers for JieYa Co. include the expansion of existing brand client businesses and the construction of the U.S. factory [1]

机构简介： 上海牧鑫资产管理有限公司成立于2014年，注册资本1000万，已取得基金业协会私募投资基金管理人资 格（登记编号：P1026632）；作为创新型资产管理公司，牧鑫资产主要专注于量化投资策略的研发、 测试、运行和管理，同时覆盖固定收益投资、另类投资及投顾服务的综合性资产管理。牧鑫资产致力于 为客户创造持续稳定的绝对收益，为国内外金融机构、企业、基金和高净值群体提供全方位的财富管 理。牧鑫资产目前产品主要专注于量化投资，坚持数量化、模型化、程序化的投资原则，以金融数学、 计量经济学、金融工程学等专业方法，研发并运行稳健的投资策略，严把风控，旨在为客户创造持续稳 定的绝对收益。除此之外，牧鑫资产还为中小金融机构提供投资顾问服务，为中小金融机构量身打造符 合自身特点的投资计划，管理其流动性，并在风险可控的情况下，实现收益最大化。牧鑫资产核心团队 成员拥有多年海内外投资研究和管理经验，教育背景囊括了数量金融工程、计算机科学、系统工程等专 业。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 根据市场公开信息及7月29日披露的机构调研 ...

证券代码：301108 证券简称：洁雅股份 公告编号：2025-056 铜陵洁雅生物科技股份有限公司 关于使用部分闲置募集资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 铜陵洁雅生物科技股份有限公司（以下简称"公司"）于 2025 年 1 月 21 日召开第五届董事会第二十四次会议和第五届监事会第二十二次会议，于 2025 年 2 月 10 日召开 2025 年第一次临时股东大会，审议通过了《关于使用部分闲置 募集资金进行现金管理的议案》，同意在确保不影响募集资金投资项目建设和公 司正常经营的前提下，使用额度不超过人民币 6 亿元的部分闲置募集资金（含超 募资金）进行现金管理，用于购买安全性高、流动性好、期限不超过 12 个月的 短期投资理财产品。使用期限自股东大会审议通过之日起 12 个月内有效。在上 述额度和期限内，资金可循环滚动使用，并授权董事长在上述额度和期限范围内 行使相关投资决策权并签署相关文件，公司财务部门具体办理相关事宜。具体内 容详见公司于 2025 年 1 月 22 日在巨潮资讯网（www.cninfo.com. ...

Company Overview - Tongling Jieya Biotechnology Co., Ltd. was established in 1999, specializing in the research, production, and sales of wet wipes, with over 20 years of industry experience [2] - The company went public on the Shenzhen Stock Exchange's Growth Enterprise Market on December 3, 2021, and is steadily advancing its fundraising projects [2] Financial Performance - In Q1 2025, the company reported a revenue of 124 million yuan and a net profit of 1,006.27 million yuan [2] Business Expansion - The company aims to increase its overseas orders to over 50% in 2025, focusing on core customer global business expansion [3] - The U.S. wet wipes factory is currently under construction and is expected to commence production next year [3] Cost Management - The U.S. factory will enhance operational efficiency and optimize cost structure through automation and improved management processes [3] Investment Risks - Key investment risks for the U.S. factory include uncertainties in facility renovation and approval processes, customer audit outcomes, potential production delays, and cultural differences affecting efficiency [3] Current Business Status - Since Q2 2025, the wet wipes business has seen stable orders from existing clients and has taken on new business from key clients in Europe and Canada [3] - The cosmetics business primarily focuses on OEM for international brands, with ongoing efforts to expand domestic client orders, albeit at a smaller scale [3] - The collagen business, established in partnership with Jiangsu Chuangjian, is currently undergoing strategic adjustments due to rapid market changes [3] Brand Development - The company's self-branded initiatives, previously funded, have not met expectations, leading to a significant reduction in investment while continuing to pursue brand development [3] Future Business Drivers - Future growth will rely on expanding existing brand client business, including product categories and sales regions, as well as leveraging the U.S. factory [4] Compliance and Governance - The investor communication event adhered to the Shenzhen Stock Exchange's regulations, ensuring no significant undisclosed information was leaked [4]